Background
Traditionally, most medical treatments have been designed for the "average patient" under the assumption that "one size fits all". Recent breakthrough in fields of diagnostics, genotyping and biomarkers enable the development of more tailor-made personalized solutions.
In the era of Personalized Medicine limited attention has so far been given to the development of dosage forms and formulations that are able to deliver requirements for optimal personalized therapy.
Sustainability
We support the United Nations’ Sustainable Development Goals and our activities are relevant for several of the goals, in particular:
Projects
The research projects spans from pharmaceutical technology, formulations and process optimization (including physico-chemical and biopharmaceutical characteristics) to the assessment of potential risks of not-optimal solutions in a clinical context.
Central technologies and delivery systems
3D-printing and hot-melt extrusion
Mucosal drug delivery
Amorphous solid dispersions
Multi-functional tablets
Project portfolio
Age-appropriate dosage forms for children
Mucoadhesive films for site-specific delivery to the upper intestine
Patient-centric formulations by hot-melt extrusion and 3D-printing
Effects of manipulations of adult medicine for use in children: Focus on dose accuracy and stability
Compatibility of i.v. drugs in paediatric intensive care
Collaboration
- Professor Natasa Skalko-Basnet, Department of Pharmacy, UiT The Arctic University of Norway
- Ass. Professor Željka Vanić, Faculty of Pharmacy and Biochemistry, University of Zagreb, Kroatia
- Professor Ganesh Acharya and professor Purusotam Basnet, University Hospital of North Norway/UiT
- Senior scientist Dr. Ellen Bruzell, Nordic Institute of Dental Materials (NIOM)
- Professor Niklas Sandler, Åbo Akademi University, Finland
- Dr. Sofia Mattsson, Umeå University, Sverige
- Senior researcher Dr. Siri Wang, Statens Legemiddelverk
- Hospital pharmacist Ingrid Grønlie, Medicines for Children Network, Norway